Information about the product

Susceptibility to gluten sensitivity is, in part, genetically determined. The strong predisposition is associated with HLA-DQ alleles, encoding the α and ß chains of two molecules of the Major Histocompatibility Complex (MHC) class II.

In most populations studied, 90-95% of patients carry the HLA-DQ2 heterodimer encoded by the alleles DQA1*05 and DQB1*02 in cis position or in trans position. The remaining patients (5-10%) usually carry a second heterodimer, HLADQ8 (majority among South American indigenous patients), encoded by the alleles DQA1*03:01 and DQB1*03:02. It is estimated that only 0.5% of celiac patients aren’t DQ2 or DQ8.

Intended Use

Genvinset® HLA Celiac is a semi-automated in vitro diagnostic kit for the qualitative detection of the HLA-DQB1*02, DQB1*03:02 and DQA1*05 alleles in genomic DNA extracted from whole blood, and the consequent determina­tion of the DQ2 and DQ8 antigens, associated with celiac disease predisposition. The kit is able to determine the homozygosity or heterozygosity status for the DQB1*02 alleles. The analysis is based on real-time PCR technology, using TaqMan® probes.

Patients who can benefit from this determination are those referred by a specialist. The results of this test should not be the only ones on which the therapeutic decision is based and should be used as an aid in the diagnosis together with results of other markers of the disease.

The intended user of the kit is technical personnel trained to carry out the protocol and the interpretation of results described in the instructions for use.

Workflow

workflow genvinset 2
Genvinset® HLA Celiac 6

Results

Genvinset HLA Celiac DQ2 homozygous sample
Genvinset HLA Celiac DQB sample
Genvinset HLA Celiac Negative sample
leyenda 4

Limitations

  • Mutations or polymorphisms at annealing primer/probe sites are possible and may result in the lack of allele definition. Other technologies could be necessary to resolve the typing.
  • Data and result interpretation should be revised by qualified personnel.
  • This product is an auxiliary tool for the diagnosis of patients with suspected celiac disease. Use these results in conjunction with clinical data and results of other tests performed on the patient.

Area:

HLA associated diseases, HLA associated diseases, Immunology, Molecular Genetics, Targeted study of specific pathologies

Documents:

Consult our experts

Google reCaptcha: Invalid site key.

Related products

Genvinset® deltaF508

Genvinset® deltaF508 is a semi‑automated in vitro diagnostic kit for the qualitative detection of wild‑type and/or F508del alleles of the CFTR gene, associated with cystic fibrosis. The assay is performed on genomic DNA extracted from whole blood using real‑time PCR with TaqMan® probes. Detailed description Key features Genvinset® deltaF508 is designed for the molecular determination…
Blackhills Diagnostic Resources
Real Time PCR (qPCR)

Emedgene

Emedgene™ software is designed to optimise variant interpretation in rare diseases and other germline applications. It combines explainable artificial intelligence, automation and configurable workflows to reduce the variant curation burden and accelerate tertiary analysis. Detailed description Key features It is a comprehensive solution developed to streamline genetic interpretation workflows and reduce the manual effort associated…
Illumina

Devyser LynchFAP

Devyser LynchFAP is a targeted NGS solution for the analysis of germline variants associated with hereditary colorectal cancer syndromes. The assay enables the detection of SNVs, indels, and CNVs in genes related to Lynch syndrome, familial adenomatous polyposis (FAP), and MUTYH-associated polyposis (MAP), also incorporating a specific LR-PCR for the correct localization of variants in…
Devyser
Next Generation Sequencing (NGS)

Devyser HBOC NGS

Devyser HBOC NGS is a fast and robust NGS solution aimed at the detection of germline variants in 12 genes associated with an increased risk of hereditary breast and ovarian cancer: ATM, BARD1, BRIP1, CDH1, CHEK2, NBN, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53. It offers comprehensive and uniform coverage of all coding exons and exon/intron…
Devyser
Next Generation Sequencing (NGS)